Jiangsu Gdk Biological Technology Co., Ltd (SHA:688670)
China
· Delayed Price · Currency is CNY 17.87
+0.14 (0.79%)
Apr 30, 2026, 1:54 PM CST
SHA:688670 Revenue
Jiangsu Gdk Biological Technology had revenue of 898.80K CNY in the quarter ending March 31, 2026, a decrease of -74.05%. This brings the company's revenue in the last twelve months to 110.32M, up 39.21% year-over-year. In the year 2025, Jiangsu Gdk Biological Technology had annual revenue of 112.88M with 39.70% growth.
Revenue (ttm)
110.32M
Revenue Growth
+39.21%
P/S Ratio
19.80
Revenue / Employee
244.07K
Employees
449
Market Cap
2.18B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu CoWin Biotech | 193.52M |
| Guiyang Xintian Pharmaceutical | 749.72M |
| Zhejiang East Asia Pharmaceutical | 940.19M |
| Shanghai Hile Bio-Technology | 246.35M |
| Shanghai Universal Biotech | 1.07B |
| Suzhou Fushilai Pharmaceutical | 412.51M |
| Cabio Biotech (Wuhan) | 418.18M |
| Jilin Jian Yisheng Pharmaceutical | 659.66M |